Cargando…

Hematological Adverse events and Sustained Viral Response in Children Undergoing Therapy for Chronic Hepatitis C Infection

BACKGROUND: Treatment of hepatitis C virus (HCV) infection with interferon (IFN) and ribavirin (RBV) is associated with adverse events, which may affect the patient's adherence to the treatment regimen and the treatment efficacy. OBJECTIVES: The aim of this study was to assess the sustained vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawlowska, Malgorzata, Pilarczyk, Malgorzata, Foksinska, Anna, Smukalska, Ewa, Halota, Waldemar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282029/ https://www.ncbi.nlm.nih.gov/pubmed/22368680 http://dx.doi.org/10.5812/kowsar.1735143X.789

Ejemplares similares

Vertical genotype 1 HCV infection treated successfully in the second year of life: A case report
por: Pawłowska, Małgorzata, et al.
Publicado: (2012)

Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus
por: Domagalski, Krzysztof, et al.
Publicado: (2016)

HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B
por: Pawłowska, M., et al.
Publicado: (2011)

Sustained Viral Response and Hematological Adverse Events in Children With Chronic Hepatitis C
por: Vigano, Alessandra, et al.
Publicado: (2012)

Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4
por: Domagalski, K., et al.
Publicado: (2013)

Sustained Viral Response and Hematological Adverse Events During Chronic Hepatitis C Infection Treatment
por: El-Shabrawi, Mortada, et al.
Publicado: (2012)

The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C
por: Domagalski, Krzysztof, et al.
Publicado: (2015)

Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz
por: Tyczyno, Malgorzata, et al.
Publicado: (2014)

Evaluation of the effectiveness of treatment with prednisone and azathioprine of autoimmune hepatitis in children
por: Pniewska, Anna, et al.
Publicado: (2015)

Hepatitis C virus infection in children in the era of direct-acting antiviral
por: Pawlowska, Malgorzata, et al.
Publicado: (2018)

Recommendations for the treatment of hepatitis C in 2017
por: Halota, Waldemar, et al.
Publicado: (2017)

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020
por: Halota, Waldemar, et al.
Publicado: (2020)

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts – 2015
por: Halota, Waldemar, et al.
Publicado: (2015)

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts – 2016
por: Halota, Waldemar, et al.
Publicado: (2016)

Recommendations for the treatment of hepatitis B in 2017
por: Flisiak, Robert, et al.
Publicado: (2017)

Sustained Viral Response Hematological Markers During The Treatment of Chronic Hepatitis C Infection in Children
por: Garcia-Algar, Oscar, et al.
Publicado: (2012)

Searching for the optimal population for hepatitis C virus screening in Poland
por: Piekarska, Anna, et al.
Publicado: (2020)

The Seroprevalence of SARS-CoV-2 IgG Antibodies in Children Hospitalized for Reasons Other Than COVID-19
por: Franczak, Justyna, et al.
Publicado: (2022)

Continuous up to 4 Years Entecavir Treatment of HBV-Infected Adolescents – A Longitudinal Study in Real Life
por: Pawłowska, Małgorzata, et al.
Publicado: (2016)

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
por: Kozielewicz, Dorota, et al.
Publicado: (2015)

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018)

Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4
por: Domagalski, Krzysztof, et al.
Publicado: (2013)

A comparison of selenium concentrations in selected organs of wild boar (Sus scrofa) from industrialized and non-industrialized regions of Poland
por: Nowakowska, Ewa, et al.
Publicado: (2018)

Management of Hematologic Adverse Events Associated With Immune Checkpoint Inhibitors
por: Rogers, Barbara Barnes, et al.
Publicado: (2021)

Efficacy of 8- versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-week regimen in a real-world setting
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2019)

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study
por: Janczewska, Ewa, et al.
Publicado: (2021)

Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone
por: Alkharabsheh, Omar, et al.
Publicado: (2023)

Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-Analysis
por: Kronick, Olivia, et al.
Publicado: (2023)

Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
por: Poręba, Małgorzata, et al.
Publicado: (2015)

Delayed Adverse Events after Procedural Sedation in Pediatric Patients with Hematologic Malignancies
por: Joo, Jin, et al.
Publicado: (2022)

Distribution of HBV genotypes in Poland
por: Świderska, Magdalena, et al.
Publicado: (2015)

Acute-on-chronic hepatitis. A case report of autoimmune hepatitis/primary sclerosing cholangitis/ulcerative colitis overlap syndrome in a 15-year-old patient
por: Nalepa, Aneta, et al.
Publicado: (2017)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
por: Zhuang, Junling, et al.
Publicado: (2020)

Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review
por: de Fraga, Raquel Scherer, et al.
Publicado: (2020)

Intestinal Alterations, Basal Hematology, and Biochemical Parameters in Adolescent Rats Fed Different Sources of Dietary Copper
por: Tomaszewska, Ewa, et al.
Publicado: (2015)

Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes
por: Allard, Nicole L., et al.
Publicado: (2020)

Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
por: Pawłowska, Małgorzata, et al.
Publicado: (2019)

Perihepatic lymphadenopathy in children with chronic viral hepatitis
por: Schreiber-Dietrich, Dagmar, et al.
Publicado: (2015)

Venous thromboembolism in children undergoing surgery: incidence, risk factors and related adverse events
por: Mets, Elbert Johann, et al.
Publicado: (2020)

Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review
por: Omar, Nabil E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_32t431oli9v976abiiif34h82p